These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34858989)

  • 1. Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology.
    Kühn R; Mahajan A; Canoll P; Hargus G
    Front Cell Dev Biol; 2021; 9():766773. PubMed ID: 34858989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Neurodegenerative Changes in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia Linked to Mutant TAU Protein.
    Ehrlich M; Hallmann AL; Reinhardt P; Araúzo-Bravo MJ; Korr S; Röpke A; Psathaki OE; Ehling P; Meuth SG; Oblak AL; Murrell JR; Ghetti B; Zaehres H; Schöler HR; Sterneckert J; Kuhlmann T; Hargus G
    Stem Cell Reports; 2015 Jul; 5(1):83-96. PubMed ID: 26143746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells.
    Lines G; Casey JM; Preza E; Wray S
    Mol Cell Neurosci; 2020 Dec; 109():103553. PubMed ID: 32956830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
    Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
    Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological Progression Induced by the Frontotemporal Dementia-Associated R406W Tau Mutation in Patient-Derived iPSCs.
    Nakamura M; Shiozawa S; Tsuboi D; Amano M; Watanabe H; Maeda S; Kimura T; Yoshimatsu S; Kisa F; Karch CM; Miyasaka T; Takashima A; Sahara N; Hisanaga SI; Ikeuchi T; Kaibuchi K; Okano H
    Stem Cell Reports; 2019 Oct; 13(4):684-699. PubMed ID: 31543469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of Frontotemporal Dementia Using iPSC Technology.
    Kim M; Kim HJ; Koh W; Li L; Heo H; Cho H; Lyoo CH; Seo SW; Kim EJ; Nakanishi M; Na DL; Song J
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.
    van Swieten JC; Heutink P
    Lancet Neurol; 2008 Oct; 7(10):965-74. PubMed ID: 18771956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: Induced pluripotent stem cell models of frontotemporal dementia.
    Preza E; Hardy J; Warner T; Wray S
    Neuropathol Appl Neurobiol; 2016 Oct; 42(6):497-520. PubMed ID: 27291591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking Site-Specific Cleavage of Human Tau Delays Progression of Disease-Related Phenotypes in Genetically Matched Tau-Transgenic Mice Modeling Frontotemporal Dementia.
    Steuer EL; Kemper LJ; Hlynialuk CJW; Leinonen-Wright K; Montonye ML; Lapcinski IP; Forster CL; Ashe KH; Liu P
    J Neurosci; 2022 Jun; 42(23):4737-4754. PubMed ID: 35508385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubules Deform the Nuclear Membrane and Disrupt Nucleocytoplasmic Transport in Tau-Mediated Frontotemporal Dementia.
    Paonessa F; Evans LD; Solanki R; Larrieu D; Wray S; Hardy J; Jackson SP; Livesey FJ
    Cell Rep; 2019 Jan; 26(3):582-593.e5. PubMed ID: 30650353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
    Seltman RE; Matthews BR
    CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling ALS and FTD with iPSC-derived neurons.
    Lee S; Huang EJ
    Brain Res; 2017 Feb; 1656():88-97. PubMed ID: 26462653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons.
    Al-Dalahmah O; Lam M; McInvale JJ; Qu W; Nguyen T; Mun JY; Kwon S; Ifediora N; Mahajan A; Humala N; Winters T; Angeles E; Jakubiak KA; Kühn R; Kim YA; De Rosa MC; Doege CA; Paryani F; Flowers X; Dovas A; Mela A; Lu H; DeTure MA; Vonsattel JP; Wszolek ZK; Dickson DW; Kuhlmann T; Zaehres H; Schöler HR; Sproul AA; Siegelin MD; De Jager PL; Goldman JE; Menon V; Canoll P; Hargus G
    Cell Stem Cell; 2024 May; 31(5):676-693.e10. PubMed ID: 38626772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.
    Lladó A; Sánchez-Valle R; Rey MJ; Ezquerra M; Tolosa E; Ferrer I; Molinuevo JL;
    J Neurol; 2008 Apr; 255(4):488-94. PubMed ID: 18357425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein.
    Taniguchi S; McDonagh AM; Pickering-Brown SM; Umeda Y; Iwatsubo T; Hasegawa M; Mann DM
    Neuropathol Appl Neurobiol; 2004 Feb; 30(1):1-18. PubMed ID: 14720172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review.
    Pan XD; Chen XC
    Transl Neurodegener; 2013 Apr; 2(1):8. PubMed ID: 23597030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling tau pathology in human stem cell derived neurons.
    Wray S
    Brain Pathol; 2017 Jul; 27(4):525-529. PubMed ID: 28585382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein.
    Hallmann AL; Araúzo-Bravo MJ; Mavrommatis L; Ehrlich M; Röpke A; Brockhaus J; Missler M; Sterneckert J; Schöler HR; Kuhlmann T; Zaehres H; Hargus G
    Sci Rep; 2017 Mar; 7():42991. PubMed ID: 28256506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.
    Sposito T; Preza E; Mahoney CJ; Setó-Salvia N; Ryan NS; Morris HR; Arber C; Devine MJ; Houlden H; Warner TT; Bushell TJ; Zagnoni M; Kunath T; Livesey FJ; Fox NC; Rossor MN; Hardy J; Wray S
    Hum Mol Genet; 2015 Sep; 24(18):5260-9. PubMed ID: 26136155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.